GPCR-G protein signalling and its mutational landscape in cancer—Driver or passengerGPCR-G蛋白信号传导及其在癌症中的突变景观——驱动因子还是乘客British Journal of PharmacologyIF7.72025-06-120OA
The effect of cancer-associated mutations on ligand binding and receptor function - A case for the 5-HT2C receptorEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72024-12-010OAAI
Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma modelMOLECULAR THERAPY ONCOLYTICSIF5.32022-09-019OAAI
Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor FunctionsMOLECULESIF4.62022-07-224OAAI
Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine (vol 141, pg 13, 2017)BIOMATERIALSIF12.92020-07-010PREAI
Dual-Stimuli-Responsive Gut Microbiota-Targeting Berberine-CS/PT-NPs Improved Metabolic Status in Obese Hamsters (vol 29, 1808197, 2019)ADVANCED FUNCTIONAL MATERIALSIF192020-03-264OAAI
Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2BIOMEDICINE & PHARMACOTHERAPYIF7.52020-01-0120OAAI
Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseasesNATURE COMMUNICATIONSIF15.72019-04-3050OAAI
Dual-Stimuli-Responsive Gut Microbiota-Targeting Berberine-CS/PT-NPs Improved Metabolic Status in Obese HamstersADVANCED FUNCTIONAL MATERIALSIF192019-02-1845PREAI
Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancerDRUG DELIVERYIF8.12017-10-1014OAAI
Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murineBIOMATERIALSIF12.92017-10-0133PREAI